21957-39-1

Basic information

• Product Name: (S)-methyl 2-amino-6-(benzyloxycarbonylamino)hexanoate
• Synonyms: (S)-methyl 2-amino-6-(benzyloxycarbonylamino)hexanoate
• CAS NO: 21957-39-1
• Molecular Weight: 294.351
• Mol File: 21957-39-1.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (S)-methyl 2-amino-6-(benzyloxycarbonylamino)hexanoate(CAS DataBase Reference)
• NIST Chemistry Reference: (S)-methyl 2-amino-6-(benzyloxycarbonylamino)hexanoate(21957-39-1)
• EPA Substance Registry System: (S)-methyl 2-amino-6-(benzyloxycarbonylamino)hexanoate(21957-39-1)

Safety Data

• Hazardous Substances Data: 21957-39-1(Hazardous Substances Data)

Upstream product

• 67-56-1 methanol 
• 32302-83-3 N-ε-benzyloxycarbonyl lysine 
• 179675-13-9 Boc-L-Lys(Z)OH 
• 73548-77-3 Boc-L-Lys(Z)-OMe 

Downstream Products

• 27317-68-6 Boc-(Z)-Lys-(Z)-Lys-OCH₃ 
• 82830-83-9 6-benzyloxycarbonylamino-2-oxo-hexanoic acid methyl ester 

Relevant articles and documents

Novel compositions of TLR7 and/or TLR8 agonists conjugated to lipids

The present invention concerns a conjugated compound of formula Q-Z-R4 wherein Q is a TLR7 and/or TLR8 agonist and Z-R4 is a lipid covalently linked to an amino acid or peptide coupled to a polyamine group, and a process for the manufacture of said conjugated compound, as well as a complex formed between said conjugated compound and a polyanionic molecule and a pharmaceutical composition containing said conjugated compound or complex. The invention further concerns the use of said conjugated compound or complex in the treatment of infection, cancer or immune disorders or for use in vaccines.